Prothrombin
- Generic Name
- Prothrombin
- Brand Names
- Balfaxar, Beriplex, Kcentra, Octaplex
- Drug Type
- Biotech
- CAS Number
- 9001-26-7
- Unique Ingredient Identifier
- 8FB1K07F16
Overview
Prothrombin Complex Concentrate (Human), is indicated for the urgent reversal of acquired coagulation factor deficiency induced by Vitamin K antagonist (VKA, e.g., warfarin) therapy in adult patients with acute major bleeding.
Background
Prothrombin Complex Concentrate (Human), is indicated for the urgent reversal of acquired coagulation factor deficiency induced by Vitamin K antagonist (VKA, e.g., warfarin) therapy in adult patients with acute major bleeding.
Indication
For use in the emergency reversal of coagulation factor deficiency in patients receiving vitamin K antagonist therapy. Prothrombin is administered as part of a cocktail containing several coagulation factors.
Associated Conditions
- Bleeding
- Vitamin K antagonist induced major bleeding
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
OCTAPLEX POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 500 IU
Manufacturer:Octapharma Pharmazeutika Produktionsges m.b.H.(Powder), Octapharma S.A.S. (Powder), Solupharm Pharmazeutische Erzeugnisse GmbH (Solvent)
Form:INJECTION, POWDER, FOR SOLUTION
Strength:280 - 760 IU/vial
Online:Yes
Approved: 2016/01/28
Approval:SIN14933P
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath